Company glac Biotech Co., Ltd.

Equities

6553

TW0006553001

End-of-day quote Taipei Exchange Other stock markets 23:00:00 08/12/2019 GMT			5-day change	1st Jan Change
43.12 ^TWD	+0.05%		+0.14%	-.--%

2019	Glac Biotech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2019	CI
2017	Glac Biotech Co., Ltd. completed the acquisition of Glory Biotech Co., Ltd..	CI

Business Summary

Glac Biotech Co Ltd is a Taiwan-based company principally engaged in research and development, manufacturing and sale of probiotics- and fermentation-related application products. The Company manufactures microencapsulated functional probiotic powder, leavening agents, as well as application products such as fermented concentrated solution and others. Its products are applied in medicine, health food, food, animal husbandry and other areas. The Company mainly distributes its products to Mainland China, Taiwan and other markets.

Managers

Managers	Title	Age	Since
Chung Wei Kuo CEO	Chief Executive Officer	-	04/08/08
Sheng Hung Huang DFI	Director of Finance/CFO	-	06/07/14
Pei Shan Hsieh CTO	Chief Tech/Sci/R&D Officer	-	04/08/08

Members of the board

Members of the board	Title	Age	Since
Wan Lai Cheng BRD	Director/Board Member	-	29/07/08
Chung Liang Li BRD	Director/Board Member	71	-
Jung Chin Lin CHM	Chairman	70	20/07/08
Chi Hsing Chang BRD	Director/Board Member	-	30/03/16
Chung Wei Kuo CEO	Chief Executive Officer	-	04/08/08
Zhong Chuan Shi BRD	Director/Board Member	-	30/03/16
Han Jia Lin BRD	Director/Board Member	-	13/05/18

Company contact information

glac Biotech Co., Ltd.

4F-2 No.17, Guoji Road

744 42, Tainan

http://www.glac.com.tw

Sector

This company's sector is not yet available